Management of adults and children receiving CAR T-cell therapy: 2021 best practice recommendations of the European Society for Blood and Marrow Transplantation (EBMT) and the Joint Accreditation Committee of ISCT and EBMT (JACIE) and the European Haematology Association (EHA)
- DOI
- 10.1016/j.annonc.2021.12.003
- Published
- 2022-03
- Container
- Annals of Oncology
- Publisher
- Elsevier BV
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1016/j.annonc.2021.12.003,
title = {Management of adults and children receiving CAR T-cell therapy: 2021 best practice recommendations of the European Society for Blood and Marrow Transplantation (EBMT) and the Joint Accreditation Committee of ISCT and EBMT (JACIE) and the European Haematology Association (EHA)},
author = {P.J. Hayden and C. Roddie and P. Bader and G.W. Basak and H. Bonig and C. Bonini and C. Chabannon and F. Ciceri and S. Corbacioglu and R. Ellard and F. Sanchez-Guijo and U. Jäger and M. Hildebrandt and M. Hudecek and M.J. Kersten and U. Köhl and J. Kuball and S. Mielke and M. Mohty and J. Murray and A. Nagler and J. Rees and C. Rioufol and R. Saccardi and J.A. Snowden and J. Styczynski and M. Subklewe and C. Thieblemont and M. Topp and Á.U. Ispizua and D. Chen and R. Vrhovac and J.G. Gribben and N. Kröger and H. Einsele and I. Yakoub-Agha},
year = {2022},
journal = {Annals of Oncology},
doi = {10.1016/j.annonc.2021.12.003},
url = {https://doi.org/10.1016/j.annonc.2021.12.003}
}RIS
TY - JOUR TI - Management of adults and children receiving CAR T-cell therapy: 2021 best practice recommendations of the European Society for Blood and Marrow Transplantation (EBMT) and the Joint Accreditation Committee of ISCT and EBMT (JACIE) and the European Haematology Association (EHA) AU - P.J. Hayden AU - C. Roddie AU - P. Bader AU - G.W. Basak AU - H. Bonig AU - C. Bonini AU - C. Chabannon AU - F. Ciceri AU - S. Corbacioglu AU - R. Ellard AU - F. Sanchez-Guijo AU - U. Jäger AU - M. Hildebrandt AU - M. Hudecek AU - M.J. Kersten AU - U. Köhl AU - J. Kuball AU - S. Mielke AU - M. Mohty AU - J. Murray AU - A. Nagler AU - J. Rees AU - C. Rioufol AU - R. Saccardi AU - J.A. Snowden AU - J. Styczynski AU - M. Subklewe AU - C. Thieblemont AU - M. Topp AU - Á.U. Ispizua AU - D. Chen AU - R. Vrhovac AU - J.G. Gribben AU - N. Kröger AU - H. Einsele AU - I. Yakoub-Agha PY - 2022 JO - Annals of Oncology DO - 10.1016/j.annonc.2021.12.003 UR - https://doi.org/10.1016/j.annonc.2021.12.003 ER -
APA
Hayden, P., Roddie, C., Bader, P., Basak, G., Bonig, H., Bonini, C., Chabannon, C., Ciceri, F., Corbacioglu, S., Ellard, R., Sanchez-Guijo, F., Jäger, U., Hildebrandt, M., Hudecek, M., Kersten, M., Köhl, U., Kuball, J., Mielke, S., Mohty, M., Murray, J., Nagler, A., Rees, J., Rioufol, C., Saccardi, R., Snowden, J., Styczynski, J., Subklewe, M., Thieblemont, C., Topp, M., Ispizua, Á., Chen, D., Vrhovac, R., Gribben, J., Kröger, N., Einsele, H., & Yakoub-Agha, I. (2022). Management of adults and children receiving CAR T-cell therapy: 2021 best practice recommendations of the European Society for Blood and Marrow Transplantation (EBMT) and the Joint Accreditation Committee of ISCT and EBMT (JACIE) and the European Haematology Association (EHA). Annals of Oncology. https://doi.org/10.1016/j.annonc.2021.12.003
Source records
- crossref · retrieved 2026-09-26T09:21:26.835Z